For treatment-naive patients with metastatic esophageal or gastroesophageal junction cancer, FOLFOX (oxaliplatin, leucovorin, and bolus and infusional fluorouracil) in combination with cetuximab appeared to be the least toxic of 3 chemotherapy backbone regimens, a study published in the Journal of Clinical Oncology has shown.1
http://www.cancertherapyadvisor.com/gastrointestinal-cancer-clinical-trials/optimal-chemo-backbone-for-metastatic-esophageal-cancer-assessed/article/507713/
Optimal Chemo Backbone for Metastatic Esophageal Cancer Assessed